Rockwell Medical Inc (FRA:RWMA)
€ 1.683 -0.015 (-0.88%) Market Cap: 52.10 Mil Enterprise Value: 57.65 Mil PE Ratio: 0 PB Ratio: 2.66 GF Score: 49/100

Q2 2022 Rockwell Medical Inc Earnings Call Transcript

Aug 15, 2022 / 12:00PM GMT
Release Date Price: €1.76 (+6.67%)
Operator

Good morning, and welcome to Rockwell Medical's Second Quarter 2022 Results Conference Call and Webcast. Please note, this event is being recorded.

At this time, I would like to turn the conference call over to Heather Hunter, SVP and Chief Affairs Officer at Rockwell Medical. Heather please go ahead

Heather Hunter

Good morning, and thank you for joining us for this update on Rockwell Medical. Joining me on today's conference call are Dr. Mark Strobeck, Rockwell's new President and CEO; and Russell Skibsted, Rockwell's Chief Financial Officer and Chief Business Officer. During today's call, Mark will provide an update on Rockwell's second quarter achievements as well as an overview of the company's strategy going forward. Then Russell will discuss Rockwell's financial results. After that, we will open the lines to take your questions. .

Before we begin, I would like to remind everyone that this conference call will be -- will contain forward-looking statements about Rockwell Medical within the meaning of the federal securities laws including, but

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot